Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Histology and Histopathology

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14670/HH-14.657PMID 10212826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concerted gene duplications in the two keratin gene families

  2005cited by this paper
• Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract

  2004cited by this paper
• Urine-TPA (Tissue Polypeptide Antigen), flowcytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma

  2004cited by this paper
• Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma

  1998cited by this paper
• Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma

  1998cited by this paper
• Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.

  1997cited by this paper
• Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.

  1997cited by this paper
• Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer.

  1997cited by this paper
• Stromal and vascular invasion in an human in vitro bladder cancer model.

  1997cited by this paper
• CYFRA 21-1 quantity measurement in the urine of patients with carcinoma of the urinary bladder and tract.

  1997cited by this paper
• Oncogenic regulation and function of keratins 8 and 18

  1996cited by this paper
• Cell-surface Cytokeratin 8 Is the Major Plasminogen Receptor on Breast Cancer Cells and Is Required for the Accelerated Activation of Cell-associated Plasminogen by Tissue-type Plasminogen Activator*

  1996cited by this paper
• Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.

  1996cited by this paper
• Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer.

  1996cited by this paper
• Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.

  1996cited by this paper
• Implications of intermediate filament protein phosphorylation

  1996cited by this paper
• Role of intermediate filaments in migration, invasion and metastasis

  1996cited by this paper
• Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples.

  1996cited by this paper
• A molecular genetic model of human bladder cancer pathogenesis.

  1996cited by this paper
• Cytokeratin 20 as an objective marker of urothelial dysplasia.

  1996cited by this paper
• Molecular genetics of bladder cancer.

  1995cited by this paper
• Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.

  1995cited by this paper
• Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent disease

  1995cited by this paper
• A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines.

  1995cited by this paper
• Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments.

  1995cited by this paper
• Two molecular pathways to transitional cell carcinoma of the bladder.

  1994cited by this paper
• Urinary bladder cancer: mechanisms of development and progression.

  1994cited by this paper
• The cellular and molecular biology of keratins: beginning a new era.

  1993cited by this paper
• Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract

  1993cited by this paper
• Keratin immunohistochemistry: update of applications and pitfalls.

  1993cited by this paper
• Immunohistochemistry in tumour diagnosis.

  1993cited by this paper
• Alterations in cytokeratin expression precede histological changes in epithelia of vitamin A-deficient rats

  1992cited by this paper
• Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

  1992cited by this paper
• Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.

  1991cited by this paper
• Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.

  1990cited by this paper
• Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns

  1990cited by this paper
• The morphology of normal human bladder urothelium.

  1989cited by this paper
• Patterns of expression of keratin 17 in human epithelia: dependency on cell position.

  1989cited by this paper
• Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

  1988cited by this paper
• Keratin expression during neoplastic progression of bladder cancer.

  1988cited by this paper
• Cytokeratin pattern in normal and pathological bladder urothelium: immunohistochemical investigation using monoclonal antibodies.

  1988cited by this paper
• Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13.

  1986cited by this paper
• Cytokeratin polypeptide patterns of different epithelia of the human male urogenital tract: immunofluorescence and gel electrophoretic studies.

  1985cited by this paper
• Intermediate Filament Proteins as Distinguishing Markers of Cell Type and Differentiated State in Cultured Human Urinary Tract Epithelia

  1985cited by this paper
• Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations.

  1985cited by this paper
• Squamous carcinoma of urinary bladder.

  1983cited by this paper
• The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia.

  1982cited by this paper
• Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies

  1982cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper

• Transcription factor ZEB2 is essential for ureteral smooth muscle cell differentiation

  2026cites this paper
• ZEB2 signaling is essential for ureteral smooth muscle cell differentiation and maintenance

  2025cites this paper
• Scientific and Regulatory Policy Committee Points to Consider*: Sample Selection, Assay Design, Data Generation and Interpretation, and Reporting Practices for Chromogenic Immunohistochemical (IHC) Assays in Nonclinical Drug Development.

  2025cites this paper
• Liquid biopsy in cancer: current status, challenges and future prospects

  2024cites this paper
• Applications of Biosensors in Bladder Cancer

  2024cites this paper
• Urinary markers for bladder cancer diagnosis: A review of current status and future challenges

  2023cites this paper
• Urine biomarkers in bladder cancer — current status and future perspectives

  2023cites this paper
• BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.

  2023cites this paper
• The difference between cytokeratin 20 expression in high- and low-grade urothelial bladder carcinomas: A cross-sectional study

  2023cites this paper
• Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children

  2023cites this paper
• Ascorbic Acid 2-Phosphate-Releasing Supercritical Carbon Dioxide-Foamed Poly(L-Lactide-Co-epsilon-Caprolactone) Scaffolds Support Urothelial Cell Growth and Enhance Human Adipose-Derived Stromal Cell Proliferation and Collagen Production

  2023cites this paper
• An immunoresponsive three-dimensional urine-tolerant human urothelial model to study urinary tract infection

  2023cites this paper
• The Development of Non-Invasive Diagnostic Tools in Bladder Cancer

  2022cites this paper
• OTT_A_283891 497..507

  2022cites this paper
• Barrier-Forming Potential of Epithelial Cells from the Exstrophic Bladder

  2022cites this paper
• Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies

  2021cites this paper
• Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset

  2021cites this paper
• Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes

  2021cites this paper
• Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications

  2021cites this paper
• Persistent urothelial differentiation changes in the reconstructed exstrophic bladder: Congenital or acquired dysfunction of the epithelial barrier?

  2021cites this paper
• Immunohistochemistry as a paramount tool in research of normal urothelium, bladder cancer and bladder pain syndrome

  2021cites this paper
• Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?

  2021cites this paper
• Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.

  2020cites this paper
• CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective

  2020cites this paper
• A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature

  2020cites this paper
• A Novel Method for Classification and Characterization of Urothelium Cell Culture Exposed to the Different PPARg Agonists

  2020cites this paper
• INSTRUCTIONS ON THE ANNOTATION OF PDF FILES

  2020cites this paper
• Immunohistochemistry of Cancers

  2020cites this paper
• Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.

  2019cites this paper
• Molecular characterization of low grade and high grade bladder cancer

  2019cites this paper
• What makes cells move: Requirements and obstacles for leader cells in collective invasion.

  2019cites this paper
• Papillary squamotransitional cell carcinoma of the uterine cervix: a case report and review of the literature

  2019cites this paper
• Single-Cell Transcriptomic Map of the Human and Mouse Bladders.

  2019cites this paper
• Use of poly(L-lactide-co-e-caprolactone) based biomaterials in urological and gynaecological tissue engineering applications

  2019influential citation
• Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas

  2018cites this paper
• 5 Merkel Cell Polyomavirus : A Causal Factor in Merkel Cell Carcinoma

  2018influential citation
• Novel and Emerging Surveillance Markers for Bladder Cancer

  2018cites this paper
• UBC® Rapid Test—A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study

  2018cites this paper
• Human Urothelial Cells Isolation, In Vitro Expansion and Characterization for Evaluating Bio-Engineering Potentials

  2018cites this paper
• Urinmarker beim Blasenkarzinom

  2018cites this paper
• Three-dimensional imaging of the developing human fetal urogenital-genital tract: Indifferent stage to male and female differentiation.

  2018cites this paper
• Three-dimensional imaging of the developing human fetal urogenital-genital tract : Indi ff erent stage to male and female di ff erentiation ☆

  2018cites this paper
• Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study

  2017cites this paper
• Renal Subcapsular xenografing of human fetal external genital tissue - A new model for investigating urethral development.

  2017cites this paper
• Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma

  2017cites this paper
• High KRT8 expression promotes tumor progression and metastasis of gastric cancer

  2017cites this paper
• UBC® Rapid Test for detection of carcinoma in situ for bladder cancer

  2017cites this paper
• Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?

  2017cites this paper
• Urothelial cell expansion and differentiation are improved by exposure to hypoxia

  2017cites this paper
• Flat Urothelial Lesions With Atypia: Interobserver Concordance and Added Value of Immunohistochemical Profiling

  2016cites this paper
• Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats

  2016cites this paper
• An immunohistochemical study of cytokeratins distribution of the human adult male and female urethra.

  2016cites this paper
• Fibroblast growth factor receptor 1 and cytokeratin 20 expressions and their relation to prognostic variables in bladder cancer.

  2016cites this paper
• Transcription factor regulation in urothelial-type differentiation and reprogramming

  2016cites this paper
• The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors

  2016influential citation
• Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.

  2015cites this paper
• Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA.

  2015cites this paper
• Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients

  2015cites this paper
• Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines

  2015cites this paper
• Organ-specific matrix self-assembled by mesenchymal cells improves the normal urothelial differentiation in vitro

  2015cites this paper
• A Novel and Faster Method to Obtain a Differentiated 3-Dimensional Tissue Engineered Bladder.

  2015cites this paper
• Production et greffe de substituts urétraux lagomorphes produits par la méthode d'auto-assemblage

  2015cites this paper
• Minichromosome maintenance complex component 7 has an important role in the invasion of papillary urothelial neoplasia.

  2015cites this paper
• Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder Cancer.

  2015cites this paper
• Intravesical gemcitabine treatment: repercussions on normal bladder function.

  2015cites this paper
• Urinary Bladder and Urachus

  2015cites this paper
• UTILITY OF A DUAL IMMUNOSTAIN LIKE P53 AND CK20 TO AID IN THE DIAGNOSIS AND CATEGORIZATION OF NEOPLASTIC BLADDER BIOPSIES

  2015cites this paper
• Novel Oncomarkers Used for Earlier Detection of Bladder Carcinoma

  2014cites this paper
• The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study

  2014cites this paper
• IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status

  2014cites this paper
• Actin Automata: Phenomenology and Localizations

  2014cites this paper
• The application of immunohistochemical biomarkers in urologic surgical pathology.

  2014cites this paper
• Tissue Engineering in Urological and Gynaecological Applications

  2014cites this paper
• Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.

  2014cites this paper
• responses in cultured urothelial cells from rat 2+ Heterogeneity of muscarinic receptor-mediated Ca

  2013cites this paper
• Novel immunohistochemical data indicate that the female foetal urethra is more than an epithelial tube.

  2013cites this paper
• Expression and function of vascular endothelial growth inhibitor in aged porcine bladder detrusor muscle cells

  2013cites this paper
• Mechanism Based Anticancer Drugs that Degrade Sp Transcription Factors

  2013cites this paper
• Characterizing and optimizing poly-l-lactide-co-ε-caprolactone membranes for urothelial tissue engineering

  2012cites this paper
• Expression and potential clinical significance of urothelial cytodifferentiation markers in the exstrophic bladder.

  2012cites this paper
• Porcine Bladder Urothelial, Myofibroblast, and Detrusor Muscle Cells: Characterization and ATP Release

  2011cites this paper
• CYFRA 21-1: A potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder

  2011cites this paper
• Expression of vimentin and high‐molecular‐weight cytokeratin (clone 34ßE12) in differentiating reactive renal tubular cells from low‐grade urothelial carcinoma cells in voided urine

  2011cites this paper
• Immunocytochemical characterisation of cultures of human bladder mucosal cells

  2011cites this paper
• Merkel Cell Polyomavirus: A Causal Factor in Merkel Cell Carcinoma

  2011influential citation
• u rinary Bladder

  2011cites this paper
• Porcine bladder urothelial, myofi broblast and detrusor muscle cells: characterisation and ATP

  2011cites this paper
• Organotypic and 3D reconstructed cultures of the human bladder and urinary tract.

  2011cites this paper
• Comparison of a poly-l-lactide-co-ɛ-caprolactone and human amniotic membrane for urothelium tissue engineering applications

  2011cites this paper
• Epithelial cells transdifferentiation into bladder urothelium in experiments in vivo

  2011cites this paper
• Fibroblast growth factor-10 signals development of von Brunn's nests in the exstrophic bladder.

  2010cites this paper
• Laboratory Medicine Practice Guidelines Use of Tumor Markers in Liver , Bladder , Cervical , and Gastric Cancers

  2010cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.

  2010cites this paper
• Proteomics Analysis of Bladder Cancer Exosomes*

  2010cites this paper
• Intestinal metaplasia of the renal pelvis.

  2010cites this paper
• Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

  2010cites this paper
• Tumormarker beim Blasentumor: Aussichten für den klinischen Alltag / Tumor markers for bladder cancer: outlook for routine use

  2010cites this paper
• Tumor markers for bladder cancer: outlook for routine use 1

  2010cites this paper
• Exosomes: a source of novel disease biomarkers in bladder cancer.

  2010cites this paper
• Cytological Pattern Profiling of Tumors from Different Visceral Sites

  2009cites this paper